Petra Hamerlik

Petra Hamerlik

Company: AstraZeneca

Job title: Director


Targeting DNA Repair in Glioblastoma: New Era of Brain Penetrant Agents 8:10 am

Aberrant DNA repair in malignant gliomas Functional interplay between cancer cell metabolism and DNA repair Brain penetrant DNA repair inhibitor efficacy in malignant gliomasRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.